Oravig Tablet
Product Images NDC 61825-303

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oravig (NDC 61825-303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Galt Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oravig-07 (Capture 1)

Patient information leaflet for Oravig (miconazole) buccal tablets 50 mg by Galt Pharmaceuticals, LLC. The text covers usage instructions, safety warnings, allergies, drug interactions, and directions for proper application and handling, including specific precautions for children and pregnant women.*

FDA Label Image

Oravig-08 (Capture 2)

This is a drug facts panel for Oravig (miconazole) buccal tablets 50 mg, containing safety information, what to avoid while using the product, possible side effects, storage instructions, and general usage information. It includes instructions on avoiding activities that prevent the tablet from sticking, lists side effects and warnings, proper storage conditions, and ingredients. Manufactured by Ca­lzae­r Germany, distributed by Galt Pharmaceuticals, LLC.*

FDA Label Image

Oravig 01 (Oravig 01)

Chemical structure of miconazole, showing its molecular arrangement with two dichlorophenyl groups connected via an ether linkage to an imidazole ring, illustrating the active ingredient in Oravig buccal tablets.*

FDA Label Image

Oravig 02 (Oravig 02)

An instructional diagram showing the placement of an Oravig 50 mg buccal tablet inside the mouth. The illustration directs to place the tablet on the upper gum adjacent to the canine or pre-molar, highlighting the specific area for application.*

FDA Label Image

Oravig 03 (Oravig 03)

Oravig 50 mg buccal tablet, white and round with a flat edge and an embossed letter 'L' on one side. The images show side views and the top view of the tablet. Manufactured by Galt Pharmaceuticals, LLC.*

FDA Label Image

Oravig 04 (Oravig 04)

An instructional illustration showing a person placing a buccal tablet inside the mouth against the gum, near the upper molars, demonstrating the correct method to apply a buccal tablet.*

FDA Label Image

Oravig 05 (Oravig 05)

An instructional illustration showing a person applying a buccal tablet to the upper gum inside the mouth using their finger, demonstrating the intended placement method for a buccal tablet dosage form such as Oravig (miconazole).*

FDA Label Image

Oraviag06 (Oravig 06)

The packaging label for Oravig, miconazole buccal tablets 50 mg, shows a white and blue design with text indicating 14 tablets per package. The label includes the product name Oravig with the generic name miconazole buccal tablets 50 mg prominently displayed, along with the NDC 61825-303-14. It also states 'Rx only' and includes manufacturer information for Galt Pharmaceuticals, LLC. The label features barcodes and usage instructions for the buccal route.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.